Autoimmune thyroid disease risk for pancreatic islet autoimmunity
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study checks if people with autoimmune thyroid disease may also be at risk for developing type 1 diabetes. It looks at the body's attack on insulin-producing cells in the pancreas, using blood tests to catch early signs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have autoimmune thyroid disease, and you've tested positive for at least one specific antibody (TPOAb, TgAb, TRAb, or TSI).
- You do not already have diabetes or take diabetes medication.
- You have not used strong immune-suppressing drugs or high-dose steroids in the last 3 months.
- You are not pregnant or breastfeeding.
- You do not have severe heart, liver, or kidney problems, or any condition that would make trial participation unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have islet autoantibodies (markers in the blood that can increase the risk of type 1 diabetes) but do not have diabetes yet. The goal is to better understand how these antibodies affect health over time.
This study checks for certain thyroid-related antibodies in people with diabetes, which might help understand a link between diabetes and thyroid health.
This study looks for people at high risk of developing type 1 diabetes (based on family history or blood markers) and follows them over time to understand disease development. The goal is to eventually prevent or delay type 1 diabetes in people who don't have it yet.
This study screens close family members of people with type 1 diabetes for early signs of the condition. A simple blood test looks for special markers (autoantibodies) that can show if the immune system is starting to attack the pancreas. Finding these markers early may help doctors prevent or delay the onset of diabetes.
This study enrolls people with islet autoantibodies, which are early markers for type 1 diabetes. It aims to understand who develops these antibodies and how they are linked to diabetes over time. No treatment is given—you just provide blood samples and answer questions.
This study follows children who are at genetic risk for type 1 diabetes or have early immune signs (autoantibodies) but do not yet need insulin. It provides extra checkups and information to catch the disease early and help families understand their child's risk.
Hear when a new Autoimmune Thyroid Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.